Lange PH - Search Results

1

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration.

Bladou F, Vessella RL, Buhler KR, Ellis WJ, True LD, Lange PH. Bladou F, et al. Among authors: lange ph. Int J Cancer. 1996 Sep 17;67(6):785-90. doi: 10.1002/(SICI)1097-0215(19960917)67:6<785::AID-IJC6>3.0.CO;2-N. Int J Cancer. 1996. PMID: 8824549

2

Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.

Liu AY, Corey E, Bladou F, Lange PH, Vessella RL. Liu AY, et al. Among authors: lange ph. Int J Cancer. 1996 Jan 3;65(1):85-9. doi: 10.1002/(SICI)1097-0215(19960103)65:1<85::AID-IJC15>3.0.CO;2-H. Int J Cancer. 1996. PMID: 8543402

3

Issues in the assessment of prostate-specific antigen immunoassays. An update.

Vessella RL, Lange PH. Vessella RL, et al. Among authors: lange ph. Urol Clin North Am. 1997 May;24(2):261-8. doi: 10.1016/s0094-0143(05)70371-2. Urol Clin North Am. 1997. PMID: 9126222

4

Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.

Corey E, Wegner SK, Stray JE, Corey MJ, Arfman EW, Lange PH, Vessella RL. Corey E, et al. Among authors: lange ph. Int J Cancer. 1997 Jun 11;71(6):1019-28. doi: 10.1002/(sici)1097-0215(19970611)71:6<1019::aid-ijc18>3.0.co;2-8. Int J Cancer. 1997. PMID: 9185706

5

Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, Lange PH, Vessella RL. Melchior SW, et al. Among authors: lange ph. Clin Cancer Res. 1997 Feb;3(2):249-56. Clin Cancer Res. 1997. PMID: 9815680

6

Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.

Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH. Ellis WJ, et al. Among authors: lange ph. Clin Cancer Res. 1996 Jun;2(6):1039-48. Clin Cancer Res. 1996. PMID: 9816265

7

Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.

Melchior SW, Brown LG, Figg WD, Quinn JE, Santucci RA, Brunner J, Thüroff JW, Lange PH, Vessella RL. Melchior SW, et al. Among authors: lange ph. Int J Oncol. 1999 Mar;14(3):501-8. doi: 10.3892/ijo.14.3.501. Int J Oncol. 1999. PMID: 10024683

8

Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone.

Lange PH, Vessella RL. Lange PH, et al. Cancer Metastasis Rev. 1998-1999;17(4):331-6. doi: 10.1023/a:1006106209527. Cancer Metastasis Rev. 1998. PMID: 10453276 Review.

9

Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft model.

Buhler KR, Santucci RA, Royai RA, Whitney SC, Vessella RL, Lange PH, Ellis WJ. Buhler KR, et al. Among authors: lange ph. Prostate. 2000 Apr 1;43(1):63-70. doi: 10.1002/(sici)1097-0045(20000401)43:1<63::aid-pros9>3.0.co;2-d. Prostate. 2000. PMID: 10725867

10

Differential expression of osteonectin/SPARC during human prostate cancer progression.

Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL. Thomas R, et al. Among authors: lange ph. Clin Cancer Res. 2000 Mar;6(3):1140-9. Clin Cancer Res. 2000. PMID: 10741745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters